EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms

Catarina Almeida, Lorenzo Gervaso iD, Gianmaria Frigè iD, Francesca Spada iD, Lavinia Benini, Chiara Alessandra Cella, Luca Mazzarella, Nicola Fazio iD

Cancers · 30.09.2024 · 16 (19) · 3349

DOI: 10.3390/cancers16193349 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.09.2024. Verfasst von Catarina Almeida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO IRCCS, 20141 Milan, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine neoplasms incidence has been increasing, arising the need for precise and early diagnostic tools. Liquid biopsy (LB) offers a less invasive alternative to tissue biopsy, providing real-time molecular information from circulating tumour components in body fluids. The aim of this review is to analyse the current evidence concerning LB in NENs and its role in clinical practice. We conducted a systematic review in July 2024 focusing on LB applications in NENs, including circulating tumour cells (CTCs), circulating tumour DNA (ctDNA), micro RNA (miRNA), messenger RNA (mRNA) and extracellular vesicles. Sixty-five relevant articles were analysed. The LB showed potential in diagnosing and monitoring NENs. While CTCs face limitations due to low shedding, ctDNA provides valuable information on high-grade neoplasms. MiRNA and mRNA (e.g., the NETest) offer high sensitivity and specificity for diagnosis and prognosis, outperforming traditional markers like chromogranin A. The LB has significant potential for NEN diagnosis and monitoring but lacks widespread clinical integration due to limited prospective studies and guidelines, requiring further validation. Advances in sequencing technologies may enhance the clinical utility of LB in NENs. Future research should focus on refining LB methods, standardising protocols and exploring applications in high-grade NENs.

Schlagwörter

Stichwörter der Autor:innen

circulating tumour DNAgastroenteropancreatic tractliquid biopsyneuroendocrine neoplasmsprecision medicine

Autor:innen und Institutionen

  • Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO IRCCS, 20141 Milan, Italy.
  • Department of Medical Oncology, São João University Hospital Center, 4200-319 Porto, Portugal.
  • Laboratory of Translational Oncology, European Institute of Oncology, IEO IRCCS, 20141 Milan, Italy.

ORCID-Profile: Lorenzo Gervaso, Gianmaria Frigè, Francesca Spada, Nicola Fazio

Zitieren

APA

Almeida, C., Gervaso, L., Frigè, G., Spada, F., Benini, L., Cella, C. A., Mazzarella, L., & Fazio, N. (2024). The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers, 16(19), 3349. https://doi.org/10.3390/cancers16193349

Vancouver

Almeida C, Gervaso L, Frigè G, Spada F, Benini L, Cella CA, et al. The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers. 2024;16(19):3349. doi:10.3390/cancers16193349

BibTeX
@article{Almeida2024,
  author = {Almeida, Catarina and Gervaso, Lorenzo and Frigè, Gianmaria and Spada, Francesca and Benini, Lavinia and Cella, Chiara Alessandra and Mazzarella, Luca and Fazio, Nicola},
  title = {The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {19},
  pages = {3349},
  doi = {10.3390/cancers16193349}
}
Kostenlos starten →